What is the recommended dose of cefixime for a 4-year-old female patient with normal renal function, weighing 16-20 kg, and diagnosed with febrile urinary tract infection (UTI) caused by Escherichia coli (E. coli), for outpatient treatment of uncomplicated pyelonephritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefixime Dosing for Febrile UTI/Pyelonephritis in a 4-Year-Old

For a 4-year-old female with febrile UTI caused by E. coli, administer cefixime 8 mg/kg/day orally once daily for 10 days. 1, 2, 3

Specific Dosing Calculation

  • Standard pediatric dose: 8 mg/kg/day given as a single daily dose 1, 2
  • For a 16-20 kg child: This translates to 128-160 mg once daily 2
  • Treatment duration: 10 days is the most commonly recommended duration for febrile UTI, within the acceptable 7-14 day range 1, 3

Why This Regimen Works

Cefixime is highly effective for outpatient treatment of febrile UTI in children. A randomized controlled trial demonstrated that oral cefixime 8 mg/kg/day for 10 days achieved a 92% cure rate in pediatric UTI, with repeat urine cultures sterile within 24 hours in all children 3. The FDA-approved pediatric dose is 8 mg/kg/day for patients 6 months and older 2.

The once-daily dosing significantly improves adherence compared to multiple daily doses, which is critical for outpatient treatment success 1, 2. Cefixime achieves adequate urinary concentrations with approximately 20% excreted unchanged in urine as active drug 4.

Critical Clinical Considerations

Ensure the child can tolerate oral medications and does not appear toxic. If the child appears toxic, cannot retain oral intake, or has uncertain compliance, parenteral therapy with ceftriaxone 50 mg/kg IV/IM once daily should be initiated instead 1, 5. Once stabilized, transition to oral cefixime to complete the 10-day course 1.

Verify local E. coli resistance patterns before prescribing. Cefixime should only be used empirically if local resistance rates are acceptable 1, 4. Adjust therapy based on culture and sensitivity results when available 1.

Clinical improvement should occur within 24-48 hours. If fever persists beyond 48 hours of appropriate therapy, reevaluate for antibiotic resistance, anatomic abnormalities, or alternative diagnoses 1, 6.

Essential Follow-Up Actions

Obtain renal and bladder ultrasound (RBUS) for this first febrile UTI. The American Academy of Pediatrics recommends RBUS for all children under 2 years with first febrile UTI, though this 4-year-old falls outside that strict guideline 1. However, imaging should be considered if fever persists >48 hours, the organism is non-E. coli, or there are recurrent infections 1, 6.

Schedule clinical reassessment within 24-48 hours to confirm fever resolution and clinical improvement 1. Instruct parents to seek prompt evaluation (within 48 hours) for any future febrile illnesses, as recurrent UTI risk is significant 1.

Common Pitfalls to Avoid

Never use nitrofurantoin for febrile UTI/pyelonephritis. Nitrofurantoin does not achieve adequate serum or parenchymal concentrations to treat pyelonephritis and should only be used for uncomplicated cystitis 1, 5, 6.

Do not treat for less than 7 days. Shorter courses (1-3 days) are inferior for febrile UTIs 1, 6. The 10-day duration is optimal based on the strongest pediatric evidence 1, 3.

Avoid dividing the daily dose unless gastrointestinal side effects occur. While the FDA label allows divided dosing, once-daily administration improves compliance 2, 4. If diarrhea or abdominal discomfort develops (16% incidence), consider splitting to twice daily 2, 4.

Do not fail to obtain urine culture before starting antibiotics. This is the only opportunity for definitive diagnosis and antibiotic adjustment 1, 7.

References

Guideline

Treatment of Urinary Tract Infections in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Initial Medical Evaluation for Urinary Retention in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

First-Line Treatment for Urinary Tract Infections in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can I use cefexime (Cefexime) 400 mg twice daily (bd) for urinary tract infection (UTI)?
What are the contraindications for Cefixime (Cephalosporin antibiotic)?
Can a patient with ongoing dysuria despite 6 days of cefixime treatment for a urinary tract infection (UTI) be given a 1g single dose of azithromycin?
What is an appropriate oral cephalosporin (a type of antibiotic) for the treatment of a Group B Streptococcus (GBS) urinary tract infection (UTI)?
What is the recommended dose of Cefixime (Cephalosporin) for treating Urinary Tract Infections (UTIs)?
What is the management of chronic proximal tibial artery occlusion in an older adult with peripheral artery disease (PAD), smoking history, diabetes, hypertension, and hyperlipidemia?
What is the initial fluid of choice for adult and pediatric burn patients with varying total body surface area (TBSA) burned?
What is the next best step for a patient with left flank area pain that worsens with prolonged standing or seating, elevated C-Reactive Protein (CRP) and erythrocyte sedimentation rate (Sed rate), normal urinalysis (UA) and computed tomography (CT) of the abdomen, and normal complete blood count (CBC)?
Can Azithromycin be administered through a Nasogastric Tube (NGT) in an elderly patient with severe community-acquired pneumonia on ventilator support and meropenem, who is allergic to fluoroquinolones?
What is the recommended treatment for a patient with salivary gland stones?
What is the first-line treatment for a newly diagnosed patient with diabetes mellitus, Hemoglobin A1C (HbA1C) of 7.9%, Body Mass Index (BMI) of 34, and Fasting Blood Sugar (FBS) of 7.5 mmol/L?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.